Malignant peripheral nerve sheath tumours in the head and neck region: retrospective analysis of clinicopathological features and treatment outcomes

被引:22
|
作者
Ma, C. [1 ]
Ow, A. [2 ]
Shan, O. H. [1 ]
Wu, Y. [3 ]
Zhang, C. [1 ]
Sun, J. [1 ]
Ji, T. [1 ]
Martin, L. Pingarron [1 ]
Wang, L. [4 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Stomatol,Dept Oral & Maxillofaci, Shanghai 200011, Peoples R China
[2] Natl Univ Singapore, Fac Dent, Dept Oral & Maxillofacial Surg, Singapore 117548, Singapore
[3] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Neurosurg, Shanghai 200011, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral Pathol, Shanghai 200011, Peoples R China
关键词
malignant peripheral nerve sheath tumour; head and neck tumour; surgery; radiotherapy; chemotherapy; SOFT-TISSUE SARCOMA; DIVERGENT DIFFERENTIATION; NEUROFIBROMATOSIS; SURVIVAL;
D O I
10.1016/j.ijom.2014.03.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Malignant peripheral nerve sheath tumours (MPNST) are rare soft tissue sarcomas. The aim of this study was to assess clinicopathological characteristics and prognostic factors in order to improve the treatment of such tumours in the head and neck region. We performed a retrospective analysis of head and neck MPNST patients in our hospital between 1996 and 2012. Clinical features and pathological findings of these cases (a = 43) were summarized. In addition, prognostic variables were evaluated by univariate and multivariate analyses. The median age of the patients at presentation was 41 years. Surgery was the main treatment approach. Pertinent information regarding the presence of neurofibromatosis type 1 was found in 13 patients (30.2%). Two-thirds of these patients were admitted for a primary tumour (n = 27, 62.8%), while one-third (n = 16, 37.2%) were treated for recurrent neoplasms. The overall survival rate was 46.5%. Multivariable analysis identified tumour size, surgical margins, and postoperative radiotherapy to be independent prognostic factors. MPNST of the head and neck is extremely difficult to manage. Surgery with postoperative radiation may be the optimum choice of treatment for primary head and neck MPNST.
引用
收藏
页码:924 / 932
页数:9
相关论文
共 50 条
  • [31] Morphology of the entering and exiting nerve as a differentiating feature of benign from malignant peripheral nerve sheath tumours of the brachial plexus
    I. Pressney
    M. Khoo
    R. Khan
    P. Abernethy
    R. Hargunani
    A. Saifuddin
    Skeletal Radiology, 2021, 50 : 1557 - 1565
  • [32] Idiopathic Vocal Cord Paralysis in the Radiated Neck: A Harbinger for Malignant Peripheral Nerve Sheath Tumour
    Dziegielewski, Peter T.
    O'Hara, Carolyn
    Erickson, Bree
    Seikaly, Hadi
    Harris, Jeffrey R.
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 41 (04): : 246 - 252
  • [33] Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors
    Bradford, Diana
    Kim, AeRang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (03)
  • [34] Diagnosis, Treatment and Survival of 65 Patients with Malignant Peripheral Nerve Sheath Tumors
    Goertz, Ole
    Langer, Stefan
    Uthoff, Daniela
    Ring, Andrej
    Stricker, Ingo
    Tannapfel, Andrea
    Steinau, Hans-Ulrich
    ANTICANCER RESEARCH, 2014, 34 (02) : 777 - 783
  • [35] Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours
    Asano, Naofumi
    Yoshida, Akihiko
    Ichikawa, Hitoshi
    Mori, Taisuke
    Nakamura, Masaya
    Kawai, Akira
    Hiraoka, Nobuyoshi
    HISTOPATHOLOGY, 2017, 70 (03) : 385 - 393
  • [36] Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years
    Ingham, Sarah
    Huson, Susan M.
    Moran, Anthony
    Wylie, James
    Leahy, Michael
    Evans, D. Gareth R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (18) : 2723 - 2728
  • [37] The role of radiotherapy in the management of malignant peripheral nerve sheath tumors: a single-center retrospective cohort study
    Roohani, Siyer
    Classen, Noa Marie
    Ehret, Felix
    Jarosch, Armin
    Dziodzio, Tomasz
    Floercken, Anne
    Maerdian, Sven
    Zips, Daniel
    Kaul, David
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (20) : 17739 - 17747
  • [38] Clinical Outcomes of Carbon Ion Radiation Therapy for Malignant Peripheral Nerve Sheath Tumors
    Fiore, Maria Rosaria
    Chalaszczyk, Agnieszka
    Barcellini, Amelia
    Vitolo, Viviana
    Fontana, Giulia
    Russo, Stefania
    Rotondi, Marco
    Molinelli, Silvia
    Mirandola, Alfredo
    Bazani, Alessia
    Orlandi, Ester
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (11)
  • [39] Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors
    Diana Bradford
    AeRang Kim
    Current Treatment Options in Oncology, 2015, 16
  • [40] Extended remission of a recurrent median nerve malignant peripheral nerve sheath tumor after multimodal treatment - Case report
    Landy, H
    Feun, L
    Markoe, A
    Patchen, S
    Bruce, J
    Marcus, J
    Levi, A
    JOURNAL OF NEUROSURGERY, 2005, 103 (04) : 760 - 763